These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11728927)

  • 1. Prevention of fracture healing in rats by an inhibitor of angiogenesis.
    Hausman MR; Schaffler MB; Majeska RJ
    Bone; 2001 Dec; 29(6):560-4. PubMed ID: 11728927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNP-470: an angiogenesis inhibitor in clinical development for cancer.
    Kruger EA; Figg WD
    Expert Opin Investig Drugs; 2000 Jun; 9(6):1383-96. PubMed ID: 11060750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
    Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
    Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Earliest phases of chondrogenesis are dependent upon angiogenesis during ectopic bone formation in mice.
    Bragdon B; Lam S; Aly S; Femia A; Clark A; Hussein A; Morgan EF; Gerstenfeld LC
    Bone; 2017 Aug; 101():49-61. PubMed ID: 28412469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis inhibitor TNP-470 (AGM-1470) suppresses vascular smooth muscle cell proliferation after balloon injury in rats.
    Ogata T; Kurabayashi M; Maeno T; Sekiguchi K; Hoshino Y; Ishikawa S; Takei H; Nagai R; Morishita Y
    J Surg Res; 2003 Jun; 112(2):117-21. PubMed ID: 12888327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNP-470 inhibits intraabdominal adhesion formation.
    Chiang SC; Cheng CH; Moulton KS; Kasznica JM; Moulton SL
    J Pediatr Surg; 2000 Feb; 35(2):189-96. PubMed ID: 10693664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local inhibition of angiogenesis results in an atrophic non-union in a rat osteotomy model.
    Fassbender M; Strobel C; Rauhe JS; Bergmann C; Schmidmaier G; Wildemann B
    Eur Cell Mater; 2011 Jul; 22():1-11. PubMed ID: 21732278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rats treated with AZD2858, a GSK3 inhibitor, heal fractures rapidly without endochondral bone formation.
    Sisask G; Marsell R; Sundgren-Andersson A; Larsson S; Nilsson O; Ljunggren O; Jonsson KB
    Bone; 2013 May; 54(1):126-32. PubMed ID: 23337038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumor growth and downregulation of platelet-derived endothelial cell growth factor / thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470.
    Mori J; Haisa M; Naomoto Y; Takaoka M; Kimura M; Yamatsuji T; Notohara K; Tanaka N
    Jpn J Cancer Res; 2000 Jun; 91(6):643-50. PubMed ID: 10874218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiangiogenic treatment of cancer].
    Mauriz JL; Linares P; González P; Culebras JM
    Cir Esp; 2005 Jul; 78(1):3-11. PubMed ID: 16420784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice.
    Beecken WD; Fernandez A; Joussen AM; Achilles EG; Flynn E; Lo KM; Gillies SD; Javaherian K; Folkman J; Shing Y
    J Natl Cancer Inst; 2001 Mar; 93(5):382-7. PubMed ID: 11238700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.
    Chesler L; Goldenberg DD; Seales IT; Satchi-Fainaro R; Grimmer M; Collins R; Struett C; Nguyen KN; Kim G; Tihan T; Bao Y; Brekken RA; Bergers G; Folkman J; Weiss WA
    Cancer Res; 2007 Oct; 67(19):9435-42. PubMed ID: 17909053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis is required for successful bone induction during distraction osteogenesis.
    Fang TD; Salim A; Xia W; Nacamuli RP; Guccione S; Song HM; Carano RA; Filvaroff EH; Bednarski MD; Giaccia AJ; Longaker MT
    J Bone Miner Res; 2005 Jul; 20(7):1114-24. PubMed ID: 15940364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing.
    Simon AM; O'Connor JP
    J Bone Joint Surg Am; 2007 Mar; 89(3):500-11. PubMed ID: 17332098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude mice.
    Takei H; Lee ES; Cisneros A; Jordan VC
    Cancer Lett; 2000 Jul; 155(2):129-35. PubMed ID: 10822127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of angiogenesis inhibitor TNP-470 on vascular formation in pituitary tumors induced by estrogen in rats.
    Takechi A
    Neurol Med Chir (Tokyo); 1994 Nov; 34(11):729-33. PubMed ID: 7533265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition of 5-lipoxygenase accelerates and enhances fracture-healing.
    Cottrell JA; O'Connor JP
    J Bone Joint Surg Am; 2009 Nov; 91(11):2653-65. PubMed ID: 19884440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceleration of follicular development by administration of vascular endothelial growth factor in cycling female rats.
    Iijima K; Jiang JY; Shimizu T; Sasada H; Sato E
    J Reprod Dev; 2005 Feb; 51(1):161-8. PubMed ID: 15750308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR of the inhibition of angiogenesis by TNP-470 and ovalicin analogues: another example of an allosteric interaction.
    Mekapati SB; Hansch C
    Bioorg Med Chem; 2001 Dec; 9(12):3225-30. PubMed ID: 11711298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470.
    Ma J; Pulfer S; Li S; Chu J; Reed K; Gallo JM
    Cancer Res; 2001 Jul; 61(14):5491-8. PubMed ID: 11454697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.